Lineage Cell Therapeutics

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell LCTX and other ETFs, options, and stocks.

About LCTX

Lineage Cell Therapeutics, Inc. operates as a clinical-stage biotechnology company developing new cellular therapies for degenerative retinal diseases, neurological conditions associated with demyelination, and aiding the body in detecting and combating cancer. The company's programs are based on two core proprietary technology platforms: cell replacement and cell and drug delivery.

CEO

Brian M. Culley

CEOBrian M. Culley

Employees

Employees61

Headquarters

Carlsbad, California

HeadquartersCarlsbad, California

Founded

1990

Founded1990

Employees

Employees61

LCTX Key Statistics

Market cap

195.22M

Market cap195.22M

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

325.14K

Average volume325.14K

High today

$1.17

High today$1.17

Low today

$1.12

Low today$1.12

Open price

$1.14

Open price$1.14

Volume

118.09K

Volume118.09K

52 Week high

$2.71

52 Week high$2.71

52 Week low

$1.10

52 Week low$1.10

Analyst ratings

86%

of 7 ratings

Buy

85.7%

Hold

14.3%

Sell

LCTX Earnings

-$0.17

-$0.11

-$0.05

$0.01

Q4 FY20

Q1 FY21

Q2 FY21

Q3 FY21

Q4 FY21

Q1 FY22

Q2 FY22

Q3 FY22

Estimated

— per share

Estimated— per share

Actual

Expected Nov 10, After Hours

ActualExpected Nov 10, After Hours